Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 1/2004

01-07-2004 | Case Report

Sustained Cytogenetic Remission Induced by Imatinib Mesylate in a Chronic Myeloid Leukemia Patient Who Had a Relapse into Lymphoid Crisis after Allogeneic Hematopoietic Stem Cell Transplantation

Authors: Toshiaki Yujiri, Yutaka Sato, Yukio Tanizawa

Published in: International Journal of Hematology | Issue 1/2004

Login to get access
Metadata
Title
Sustained Cytogenetic Remission Induced by Imatinib Mesylate in a Chronic Myeloid Leukemia Patient Who Had a Relapse into Lymphoid Crisis after Allogeneic Hematopoietic Stem Cell Transplantation
Authors
Toshiaki Yujiri
Yutaka Sato
Yukio Tanizawa
Publication date
01-07-2004
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.04039

Other articles of this Issue 1/2004

International Journal of Hematology 1/2004 Go to the issue

OriginalPaper

Response to Cyclosporine Therapy in Patients with Myelodysplastic Syndrome: A Clinical Study of 12 Cases and Literature Review

OriginalPaper

Vascular Endothelial Growth Factor and Other Signaling Pathways in Developmental and Pathologic Angiogenesis

OriginalPaper

The Effects of Desflurane on Human Platelet Aggregation In Vitro

OriginalPaper

Treatment of Resistant Thrombotic Thrombocytopenic Purpura with Rituximab and Cyclophosphamide

OriginalPaper

Angiopoietin-Related/Angiopoietin-Like Proteins Regulate Angiogenesis

OriginalPaper

Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits